Browse Guides  internal medicine  pulmonology

Community-acquired pneumonia

Prevalence
Causes
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Prevention

Give elderly patients b and patients with lung disease d
  • influenza vaccine (preferably combined live and inactivated) a

Why?

  • It reduces pneumonia, hospital admissions and death in elderly patients. b
  • It causes few side effects, except sore arms. a

Influenza vaccination reduces pneumonia, hospital admissions and death

Patient Treatment Comparison Outcome CER OR
(95% CI)
NNT
(95% CI)
elderly b influenza vaccine placebo pneumonia
1.3% 0.47
(0.34 to 0.65)
150
(120 to 220)
      hospitalisation
0.79% 0.50
(0.35 to 0.72)
260
(200 to 460)
      death
1.0% 0.32
(0.24 to 0.44)
140
(130 to 170)

Intramusuclar influenza vaccination causes sore arms

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
elderly outpatient a influenza vaccine intramuscularly placebo intramuscularly sore arm
at
4.8% -330%
(-620% to -150%)
-6
(-9 to -5)

  • Elderly patients who receive combined live and inactivated influenza A vaccines are less likely to develop influenza A, without clearly having more adverse side-effects a

Combined live and inactivated vaccines reduce influenza more than inactivated alone

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
elderly in long-term care facility a combined live and inactivated vaccine inactivated vaccine laboratory-documented influenza A
at 3 years
14% 61%
(18% to 81%)
12
(7 to 43)

 

Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   M   Kamei
CAT Writers   C   Ball , CJ   Wotton , B   Phillips